ADHD As A Sociological Disorder: Know Why French Children Are Off ADHD Medications
French children are known for their healthy lifestyle as the majority of the them does not eat and mostly reject junk food. Aside from their healthy habits, French children are also off pills, especially the ones medicated for ADHD.
Read MoreTeens With ADHD Report More Concussion Symptoms
Teenage athletes with attention-deficit/hyperactivity disorder (ADHD) are more likely than their peers to report concussion-like symptoms during preseason baseline tests, a new study suggests. “This may lead us to refine the ways we use baseline concussion tests. Right now it’s a one-size-fits-all test,” said study investigator Donna Huang, MD, a resident at the Spaulding Rehabilitation…
Read MoreADHD symptom persistence into adulthood estimated
Sixty percent of children with ADHD in a recent study demonstrated persistence of symptoms into their mid-20’s, and 41 percent had both symptoms and impairment as young adults.
Read MoreDo Psychostimulants Cause Inadequate Early Morning ADHD Symptoms Management?
Poor early morning psychostimulant symptoms management for children and adolescents with attention deficit/hyperactivity disorder (ADHD) can involve functional impairment for the patients and emotional impacts for parents and caregivers, according to findings from a pair of online questionnaire studies presented at the U.S. Psychiatric & Mental Health Congress.
Read MoreCulturally sensitive treatment program serves Latino children with ADHD
When Alyson Gerdes of the Marquette University Department of Psychology met Al Castro, program director of the health research department at the United Community Center (UCC), they found that they were unknowingly working toward the same goal…Now, Gerdes and Castro run Familia Sanas (“Healthy Families”), which focuses on “disseminating a culturally-appropriate ADHD treatment to Spanish-speaking,…
Read MoreChildren of severely obese mothers at higher risk of ADHD
Babies born to severely overweight mothers have a greater chance of developing conditions such as ADHD, research has found. Public health strategies that help women planning pregnancies to reach and maintain a healthy weight could help address the risk, researchers say.
Read MoreADHD Med Okay With Mood Stabilizer in Bipolar Patients
For patients with comorbid bipolar disorder and attention-deficit/hyperactivity disorder (ADHD), the psychostimulant methylphenidate (multiple brands) can be used safely without increasing the risk for manic episodes if combined with a mood stabilizer, a large observational study suggests.
Read MorePrescription stimulants: controversies and ‘miracles’
An estimated 1 in 10 children in the United States have been diagnosed with ADHD, according to Dr. Matthew Lorber, a psychiatrist at Lenox Hill Hospital…He says Adderall, one brand of stimulant, can help with the impulsiveness, high energy, or short attention span ADHD patients may face. After a recent New York Times article discussing…
Read MorePCPs prescribing medication for ADD, depression should ‘start low, go slow’
When considering medication for children and adolescents with ADHD, depression and anxiety, PCPs should start with a low dose of a long-acting drug, and then gradually increase as needed, according to data presented at the 2016 AAP National Conference & Exhibition.
Read MoreGraduation Rate Climbs For Students With Disabilities
The U.S. Department of Education said Monday that the graduation rate for individuals with disabilities rose to 64.6 percent for the 2014-2015 school year. That’s up from 63.1 percent the year prior and represents the fourth year in a row of growth.”
Read MoreFoster Kids Face Higher Risk of Health Problems: Study
Considering the adversity foster children face, the study results aren’t surprising, the researchers added. But this is the first study to compare their rates of health issues to those of U.S. children as a whole, including kids from low-income or single-parent families.
Read MoreFDA Proposes to Withdraw Two Generic Versions of ADHD Drug Concerta
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) on Tuesday proposed withdrawing two generic versions of Janssen’s extended-release attention deficit hyperactive disorder (ADHD) drug Concerta (methylphenidate hydrochloride) two years after determining that they do not provide sufficient therapeutic effects.”
Read More